Advertisement

Search Results for "Specialty Cns Pharma Companies"

06:11 EDT 19th June 2013 | BioPortfolio

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry

MediciGlobal is a specialty patient recruitment-retention organization serving the clinical trials industry. For more than two decades, the company has led the industry in developing innovative p...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Maryland

Maryland, the US state on the mid-Atlantic coast, is hub of biotechnology institutions and companies. In 2005/2006 is was the 2nd best area globally for initiatives aimed at drawing and retaining bi...

Matching News

Pharma 3.0 Pulls Companies into the Digital Future

Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0.  Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drug...

Cinven's Mercury Pharma Buy Could Spur European Specialty Consolidation

Cinven’s $730 million acquisition of the U.K.-based specialty company Mercury Pharma could act as a platform to consolidate the sector in Europe, suggests the private equity company.

More Than Face Value: India’s Sun Pharma Buys Dusa To Build Specialty Dermatology Business

Sun Pharma is attempting to build a specialty dermatology business in the U.S., one that has limited competition and a longer term revenue visibility, but some Dusa shareholders aren’t happy.

Par Pharma To Buy 14 Generic Products From Watson And Actavis Group

WASHINGTON (dpa-AFX) - Par Pharmaceutical Companies Inc., a privately held, U.S.-based specialty pharmaceutical company, announced that it has entered into agreements with Generic drug maker Watso...

Partnering with Mylan: Generic and specialty pharma partner of choice

Mylan is a top pharmaceutical company engaged in the development and sale of generic and specialty pharmaceutical products worldwide. The company has two core businesses; both focused on advancing hig...

R&D pharma companies - comment from the Economist Intelligence Unit

Few people disagree that small drug discovery companies are vital to the health of the UK's pharma industry, and central to the government's aim of innovation-led growth. But private backers...

Big pharma will increasingly tap M&A to close $100 billion growth gap

Big pharma companies are facing a widening "growth gap" that will increase pressure to drive growth through mergers and acquisitions (M&A). But big pharma's attempts to make deals will be challenged b...

Who is determining the reputation of Pharma?

As corporate bodies, the reputation of pharma companies was typically of concern to shareholders, but generally determined by the industry or experts. Although a report just published, The Corporate...

Matching PubMed Articles

StatBite Top 10 Pharmaceutical Companies.

Companies hope for kinase inhibitor JAKpot.

Niche players in health policy: Medical specialty societies in Congress 1969-2002.

Scholars and commentators alike have long used 'organized medicine' as shorthand for the American Medical Association (AMA). However, organized medicine has increasingly shown signs of fragmentation i...

Guideline-concordant antidepressant use among patients with major depressive disorder.

OBJECTIVES: To examine whether prescriber specialty and guideline-concordant follow-up visits were associated with antidepressant treatment completion among patients with major depressive disorder (MD...

The importance of examining movements within the US health care system: sequential logit modeling.

ABSTRACT: BACKGROUND: Utilization of specialty care may not be a discrete, isolated behavior but rather, a behavior of sequential movements within the health care system. Although patients may often v...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement